세계의 백내장 수술 후 염증 치료 시장 보고서 2025 년

Post-Operative Cataract Surgery Inflammation Treatment Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

백내장 수술 후 염증 치료 시장 규모는 향후 몇 년 동안 큰 폭의 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 예상 성장은 외상성 부상 치료에 대한 접근성 향상, 첨단 약물 전달 시스템의 가용성 증가, 병용 치료의 사용 증가, 당뇨병 및 안과 동반 질환의 발생률 증가, 안과에서 개인 맞춤형 의약품의 사용 확대에 기인할 수 있습니다. 이 기간 동안의 주요 트렌드로는 수술 기술의 발전, 최첨단 약물 전달 시스템의 도입, 병용 치료의 개발, 혁신적인 항염증 치료법, AI와 디지털 건강의 통합 등이 있습니다.

외상성 부상의 발생 증가는 백내장 수술 후 염증 치료 시장의 성장을 견인할 것으로 예상됩니다. 외상성 부상은 사고, 낙상, 폭력, 스포츠 충격 등 외부의 힘에 의해 갑작스럽게 발생하는 신체적 손상으로, 경미한 상처부터 심각한 골절, 화상, 뇌 손상, 척추 손상까지 다양한 부상이 발생할 수 있습니다. 외상성 부상이 증가하는 요인으로는 도로 교통 사고, 작업장 위험, 스포츠 관련 사고, 폭력, 자연재해, 낙상에 취약한 고령화 인구 증가 등이 있습니다. 백내장 수술 후 염증 치료는 안구 염증을 줄이고 통증을 완화하며 시력 회복을 방해할 수 있는 합병증을 예방함으로써 외상성 부상을 관리하는 데 도움이 됩니다. 예를 들어, 2023년 12월 미국 정부 기관인 노동통계국은 2022년 미국의 치명적인 업무상 재해가 2021년 5,190건에서 5.7% 증가한 5,486건으로 증가하여 산업 재해가 크게 증가했다고 보고했습니다. 이러한 상승 추세는 백내장 수술 후 염증 치료에 대한 수요 증가를 더욱 강조합니다.

백내장 수술 후 염증 치료 시장을 선도하는 기업들은 치료 결과를 개선하고 환자의 회복을 향상시키기 위해 병용 치료과 같은 혁신적인 접근법을 개발하는 데 주력하고 있습니다. 병용 치료은 두 가지 이상의 약물 또는 치료 전략을 함께 사용하여 염증을 줄이고 감염을 예방하며 빠른 회복을 돕는 등 더 나은 치료 결과를 달성하기 위한 것입니다. 예를 들어, 2022년 8월, 일본에 본사를 둔 산텐 제약(Santen Pharmaceutical Co. 는 백내장 수술 후 치료를 개선하기 위해 영국과 아일랜드에서 듀크레사를 출시했습니다. 레보플록사신과 덱사메타손의 고정 용량 조합으로 감염을 예방하고 염증을 감소시켜 보다 효과적인 회복을 돕습니다. 이 치료법은 7일간 복용하도록 설계되어 환자의 편의성과 순응도를 높였습니다

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 백내장 수술 후 염증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 백내장 수술 후 염증 치료 시장 : 성장률 분석
• 세계의 백내장 수술 후 염증 치료 시장 실적 : 규모와 성장(2019-2024년)
• 세계의 백내장 수술 후 염증 치료 시장 예측 : 규모와 성장(2024-2029년, 2034년)
• 세계의 백내장 수술 후 염증 치료 총 시장 규모(TAM)

제6장 시장 세분화

• 세계의 백내장 수술 후 염증 치료 시장 : 약물 등급별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 브롬페낙
• 인도메타신
• 디클로페낙
• 풀루비프로펜
• 네파페낙
• 세계의 백내장 수술 후 염증 치료 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 경구
• 주사제
• 세계의 백내장 수술 후 염증 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 온라인 약국
• 소매 약국
• 세계의 백내장 수술 후의 염증 치료 시장 : 브롬페낙 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 브롬페낙 점안액 0.07%
• 브롬페낙 점안액 0.09%
• 브롬페낙과 병용 치료
• 세계의 백내장 수술 후의 염증 치료 시장 : 인도메타신 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 인도메타신 점안액 0.1%
• 인도메타신 경구 정제
• 인도메타신 좌제
• 세계의 백내장 수술 후의 염증 치료 시장 : 디클로페낙 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 디클로페낙 점안액 0.1%
• 디클로페낙 경구 정제
• 디클로페낙겔 및 국소제제
• 세계의 백내장 수술 후의 염증 치료 시장 : 풀루비프로펜 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 풀루비프로펜 점안액 0.03%
• 안과 수술에서 보조 사용
• 풀루비프로펜과 병용 치료
• 세계의 백내장 수술 후의 염증 치료 시장 : 네파페낙 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 네파페낙 점안액 0.1%
• 네파페낙 점안액 0.3%

제7장 지역별 및 국가별 분석

• 세계의 백내장 수술 후 염증 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 백내장 수술 후 염증 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 백내장 수술 후 염증 치료 시장 : 경쟁 구도
• 백내장 수술 후 염증 치료 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Novartis AG. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Alcon Inc 개요, 제품 및 서비스, 전략 및 재무 분석
  • Sun Pharmaceutical Industries Limited 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Bausch & Lomb Incorporated
• Santen Pharmaceutical Co. Ltd.
• Mallinckrodt plc
• Bio-Tissue Inc.
• Ocular Therapeutix Inc.
• Oculis Holding AG
• Senju Pharmaceutical Co. Ltd.
• NTC Srl
• EyePoint Pharmaceuticals Inc
• ImprimisRx LLC
• Eyenovia Inc.
• Formosa Pharmaceuticals Inc
• Nicox SA
• Surface Ophthalmics Inc.
• VivaVision Biotech Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 백내장 수술 후 염증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 백내장 수술 후 염증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 백내장 수술 후 염증 치료 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

HBR

영문 목차

영문목차

Post-operative cataract surgery inflammation treatment involves medical interventions designed to manage inflammation and discomfort following cataract surgery. These medications help control inflammation, reduce the risk of complications such as rebound iritis and pseudophakic cystoid macular edema (PCME), and support a quicker recovery.

The primary drug classes for treating post-operative inflammation following cataract surgery include bromfenac, indomethacin, diclofenac, flurbiprofen, and nepafenac. Bromfenac, a powerful NSAID used in ophthalmology, helps alleviate post-operative pain and inflammation by inhibiting COX-1 and COX-2 enzymes. These medications are available in various formulations, including oral and injectable forms, and are distributed through diverse channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

The post-operative cataract surgery inflammation treatment market research report is one of a series of new reports from The Business Research Company that provides post-operative cataract surgery inflammation treatment market statistics, including the post-operative cataract surgery inflammation treatment industry global market size, regional shares, competitors with the post-operative cataract surgery inflammation treatment market share, detailed post-operative cataract surgery inflammation treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the post-operative cataract surgery inflammation treatment industry. This post-operative cataract surgery inflammation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The post-operative cataract surgery inflammation treatment market size has grown strongly in recent years. It will grow from $4.44 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to an aging population, greater awareness of post-operative complications, a higher prevalence of ocular disorders, increased demand for effective treatments, and advancements in surgical techniques and lens implants.

The post-operative cataract surgery inflammation treatment market size is expected to see strong growth in the next few years. It will grow to $6.40 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The projected growth in the forecast period can be attributed to better access to treatment for traumatic injuries, increased availability of advanced drug delivery systems, the growing use of combination therapies, a rise in the incidence of diabetes and ocular comorbidities, and the expanding use of personalized medicine in ophthalmology. Key trends during this period include advancements in surgical techniques, the adoption of cutting-edge drug delivery systems, the development of combination therapies, innovative anti-inflammatory treatments, and the integration of AI and digital health.

The increasing occurrence of traumatic injuries is expected to drive the growth of the post-operative cataract surgery inflammation treatment market. Traumatic injuries are sudden physical harm caused by external forces such as accidents, falls, violence, or impacts from sports, and can range from minor cuts to severe fractures, burns, brain injuries, and spinal damage. Factors contributing to the rise in traumatic injuries include more road traffic accidents, workplace hazards, sports-related incidents, violence, natural disasters, and an aging population more susceptible to falls. Post-operative cataract surgery inflammation treatments help manage traumatic injuries by reducing ocular inflammation, alleviating pain, and preventing complications that could hinder visual recovery. For example, in December 2023, the Bureau of Labor Statistics, a US-based government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, a 5.7% increase from 5,190 in 2021, highlighting a significant rise in industrial accidents. This upward trend further emphasizes the growing demand for post-operative cataract surgery inflammation treatments.

Leading companies in the post-operative cataract surgery inflammation treatment market are focused on developing innovative approaches such as combination therapies to improve treatment outcomes and enhance patient recovery. Combination therapy involves using two or more medications or treatment strategies together to achieve better therapeutic results, helping reduce inflammation, prevent infection, and support faster recovery. For example, in August 2022, Santen Pharmaceutical Co. Ltd., a Japan-based company, introduced Ducressa in the UK and Ireland to improve post-cataract surgery care. This fixed-dose combination of levofloxacin and dexamethasone helps prevent infections and reduce inflammation, ensuring more effective recovery. The treatment is designed to be followed with a seven-day regimen, enhancing patient convenience and adherence.

In September 2024, Armistice Capital LLC, a US-based home healthcare service company, acquired Eyenovia Inc. for an undisclosed amount. With this acquisition, Armistice Capital LLC aims to increase its influence over Eyenovia's strategic direction and capitalize on potential growth opportunities within the ophthalmic sector. Eyenovia Inc., a US-based pharmaceutical company, specializes in treating post-operative inflammation and pain after ocular surgery using clobetasol.

Major players in the post-operative cataract surgery inflammation treatment market are Pfizer Inc., Merck & Co. Inc., Novartis AG., Alcon Inc, Sun Pharmaceutical Industries Limited, Bausch & Lomb Incorporated, Santen Pharmaceutical Co. Ltd., Mallinckrodt plc, Bio-Tissue Inc., Ocular Therapeutix Inc., Oculis Holding AG, Senju Pharmaceutical Co. Ltd., NTC Srl, EyePoint Pharmaceuticals Inc, ImprimisRx LLC, Eyenovia Inc., Formosa Pharmaceuticals Inc, Nicox S.A., Surface Ophthalmics Inc., VivaVision Biotech Inc.

North America was the largest region in the post-operative cataract surgery inflammation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in post-operative cataract surgery inflammation treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the post-operative cataract surgery inflammation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-operative cataract surgery inflammation treatment market consists of sales of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and anti-inflammatory medications. Values in this market are 'factory gate' values, meaning the value of goods sold by manufacturers, whether to other entities (including wholesalers, distributors, or directly to end customers) or downstream manufacturers. The value of goods includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Post-Operative Cataract Surgery Inflammation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-operative cataract surgery inflammation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for post-operative cataract surgery inflammation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The post-operative cataract surgery inflammation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Bromfenac; Indomethacin; Diclofenac; Flurbiprofen; Nepafenac
• 2) By Route of Administration: Oral; Injectable
• 3) By Distribution Channel: Hospital pharmacy; Online Pharmacy; Retail pharmacy
• Subsegments:
• 1) By Bromfenac: Bromfenac Ophthalmic Solution 0.07%; Bromfenac Ophthalmic Solution 0.09%; Combination Therapies With Bromfenac
• 2) By Indomethacin: Indomethacin Ophthalmic Solution 0.1%; Indomethacin Oral Capsules; Indomethacin Suppositories
• 3) By Diclofenac: Diclofenac Ophthalmic Solution 0.1%; Diclofenac Oral Tablets; Diclofenac Gel and Topical Formulations
• 4) By Flurbiprofen: Flurbiprofen Ophthalmic Solution 0.03%; Adjunctive Use In Ocular Surgery; Combination Therapies With Flurbiprofen
• 5) By Nepafenac: Nepafenac Ophthalmic Suspension 0.1%; Nepafenac Ophthalmic Suspension 0.3%
• Companies Mentioned:Pfizer Inc.; Merck & Co. Inc.; Novartis AG.; Alcon Inc; Sun Pharmaceutical Industries Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Post-Operative Cataract Surgery Inflammation Treatment Market Characteristics

3. Post-Operative Cataract Surgery Inflammation Treatment Market Trends And Strategies

4. Post-Operative Cataract Surgery Inflammation Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Post-Operative Cataract Surgery Inflammation Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Post-Operative Cataract Surgery Inflammation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Post-Operative Cataract Surgery Inflammation Treatment Market Growth Rate Analysis
• 5.4. Global Post-Operative Cataract Surgery Inflammation Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Post-Operative Cataract Surgery Inflammation Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Post-Operative Cataract Surgery Inflammation Treatment Total Addressable Market (TAM)

6. Post-Operative Cataract Surgery Inflammation Treatment Market Segmentation

• 6.1. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bromfenac
• Indomethacin
• Diclofenac
• Flurbiprofen
• Nepafenac
• 6.2. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.3. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital pharmacy
• Online Pharmacy
• Retail pharmacy
• 6.4. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Bromfenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bromfenac Ophthalmic Solution 0.07%
• Bromfenac Ophthalmic Solution 0.09%
• Combination Therapies With Bromfenac
• 6.5. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Indomethacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indomethacin Ophthalmic Solution 0.1%
• Indomethacin Oral Capsules
• Indomethacin Suppositories
• 6.6. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Diclofenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diclofenac Ophthalmic Solution 0.1%
• Diclofenac Oral Tablets
• Diclofenac Gel and Topical Formulations
• 6.7. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Flurbiprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flurbiprofen Ophthalmic Solution 0.03%
• Adjunctive Use In Ocular Surgery
• Combination Therapies With Flurbiprofen
• 6.8. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Nepafenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nepafenac Ophthalmic Suspension 0.1%
• Nepafenac Ophthalmic Suspension 0.3%

7. Post-Operative Cataract Surgery Inflammation Treatment Market Regional And Country Analysis

• 7.1. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market

• 8.1. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Post-Operative Cataract Surgery Inflammation Treatment Market

• 9.1. China Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 9.2. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Post-Operative Cataract Surgery Inflammation Treatment Market

• 10.1. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Post-Operative Cataract Surgery Inflammation Treatment Market

• 11.1. Japan Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 11.2. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Post-Operative Cataract Surgery Inflammation Treatment Market

• 12.1. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market

• 13.1. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market

• 14.1. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 14.2. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market

• 15.1. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 15.2. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Post-Operative Cataract Surgery Inflammation Treatment Market

• 16.1. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Post-Operative Cataract Surgery Inflammation Treatment Market

• 17.1. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Post-Operative Cataract Surgery Inflammation Treatment Market

• 18.1. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Post-Operative Cataract Surgery Inflammation Treatment Market

• 19.1. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Post-Operative Cataract Surgery Inflammation Treatment Market

• 20.1. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market

• 21.1. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 21.2. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Post-Operative Cataract Surgery Inflammation Treatment Market

• 22.1. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Post-Operative Cataract Surgery Inflammation Treatment Market

• 23.1. North America Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 23.2. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Post-Operative Cataract Surgery Inflammation Treatment Market

• 24.1. USA Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 24.2. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Post-Operative Cataract Surgery Inflammation Treatment Market

• 25.1. Canada Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 25.2. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Post-Operative Cataract Surgery Inflammation Treatment Market

• 26.1. South America Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 26.2. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market

• 27.1. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market

• 28.1. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 28.2. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Post-Operative Cataract Surgery Inflammation Treatment Market

• 29.1. Africa Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 29.2. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Landscape And Company Profiles

• 30.1. Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Landscape
• 30.2. Post-Operative Cataract Surgery Inflammation Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Alcon Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

31. Post-Operative Cataract Surgery Inflammation Treatment Market Other Major And Innovative Companies

• 31.1. Bausch & Lomb Incorporated
• 31.2. Santen Pharmaceutical Co. Ltd.
• 31.3. Mallinckrodt plc
• 31.4. Bio-Tissue Inc.
• 31.5. Ocular Therapeutix Inc.
• 31.6. Oculis Holding AG
• 31.7. Senju Pharmaceutical Co. Ltd.
• 31.8. NTC Srl
• 31.9. EyePoint Pharmaceuticals Inc
• 31.10. ImprimisRx LLC
• 31.11. Eyenovia Inc.
• 31.12. Formosa Pharmaceuticals Inc
• 31.13. Nicox S.A.
• 31.14. Surface Ophthalmics Inc.
• 31.15. VivaVision Biotech Inc.

32. Global Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Operative Cataract Surgery Inflammation Treatment Market

34. Recent Developments In The Post-Operative Cataract Surgery Inflammation Treatment Market

35. Post-Operative Cataract Surgery Inflammation Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer